Entities and frequency of neonatal diabetes: Data from the diabetes documentation and quality management system (DPV)

Diabetic Medicine

Volumn 27, Issue 6, 2010, Pages 709-712

  Grulich Henn, J ^a   Wagner, V ^b   Thon, A ^c   Schober, E ^d   Marg, W ^e   Kapellen, T M ^f   Haberland, H ^g   Raile, K ^g   Ellard, S ^h   Flanagan, S E ^h   Hattersley, A T ^h   Holl, R W ⁱ  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

^e Prof Hess Kinderklinik   (Germany)

^f UNIVERSITY OF LEIPZIG   (Germany)

^g CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^h UNIVERSITY OF EXETER   (United Kingdom)

ⁱ UNIVERSITY OF ULM   (Germany)

Author keywords

Children; Diabetes; Epidemiology; Molecular genetics; Neonatal diabetes

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER C8; CHROMOSOME PROTEIN; INITIATION FACTOR 2; INITIATION FACTOR 2AK3; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR PDX 1; UNCLASSIFIED DRUG; UPD6 PROTEIN;

ARTICLE; AUSTRIA; FEMALE; GENE MUTATION; GENETIC SCREENING; GERMANY; HUMAN; INCIDENCE; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MOLECULAR GENETICS; NEWBORN; NEWBORN DIABETES MELLITUS; NEWBORN DISEASE; ONSET AGE; PANCREAS AGENESIS; PANCREAS HYPOPLASIA; PANCREAS MALFORMATION; PREVALENCE;

AGE OF ONSET; AUSTRIA; DIABETES MELLITUS, TYPE 1; FEMALE; GENETIC TESTING; GERMANY; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MUTATION; RETROSPECTIVE STUDIES;

EID: 77952730370     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2010.02965.x     Document Type: Article

References (22)

1. Polak M, Cave H. Neonatal diabetes mellitus: a disease linked to multiple mechanisms. Orphanet J Rare Dis 2007 2 : 12.
2. von Muhlendahl KE, Herkenhoff H. Long-term course of neonatal diabetes. N Engl J Med 1995 333 : 704 708.
3. Aguilar-Bryan L, Bryan J. Neonatal diabetes mellitus. Endocr Rev 2008 29 : 265 291.
4. Temple IK, Shield JP. Transient neonatal diabetes, a disorder of imprinting. J Med Genet 2002 39 : 872 875.
5. Flanagan SE, Edghill EL, Gloyn AL, Ellard S, Hattersley AT. Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype. Diabetologia 2006 49 : 1190 1197.
6. Hattersley AT, Ashcroft FM. Activating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights, and new therapy. Diabetes 2005 54 : 2503 2513.
7. Edghill EL, Flanagan SE, Patch AM, Boustred C, Parrish A, Shields B et al. Insulin mutation screening in 1044 patients with diabetes: mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood. Diabetes 2008 57 : 1034 1042.
8. Shimomura K, Horster F, de Wet H, Flanagan SE, Ellard S, Hattersley AT et al. A novel mutation causing DEND syndrome: a treatable channelopathy of pancreas and brain. Neurology 2007 69 : 1342 1349.
9. Sperling MA. The genetic basis of neonatal diabetes mellitus. Pediatr Endocrinol Rev 2006 4 : S71 S75.
10. Rubio-Cabezas O, Diaz Gonzalez F, Aragones A, Argente J, Campos-Barros A. Permanent neonatal diabetes caused by a homozygous nonsense mutation in the glucokinase gene. Pediatr Diabetes 2008 9 : 245 249.
11. Grabert M, Schweiggert F, Holl RW. A framework for diabetes documentation and quality management in Germany: 10 years of experience with DPV. Comput Methods Programs Biomed 2002 69 : 115 121.
12. ATP channel subunits Kir6.2 (KCNJ11) and sulfonylurea receptor 1 (ABCC8) in diabetes mellitus and hyperinsulinism. Hum Mutat 2009 30 : 170 180.
13. Der G, Everitt BE. Handbook of Statistical Analyses using SAS, 2nd edn.
14. Rubio-Cabezas O, Minton JA, Caswell R, Shield JP, Deiss D, Sumnik Z et al. Clinical heterogeneity in patients with FOXP3 mutations presenting with permanent neonatal diabetes. Diabetes Care 2009 32 : 111 116.
15. Pearson ER, Flechtner I, Njolstad PR, Malecki MT, Flanagan SE, Larkin B et al. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med 2006 355 : 467 477.
16. Bappal B, Raghupathy P, de Silva V, Khusaiby SM. Permanent neonatal diabetes mellitus: clinical presentation and epidemiology in Oman. Arch Dis Child Fetal Neonatal Ed 1999 80 : F209 F212.
17. Stanik J, Gasperikova D, Paskova M, Barak L, Javorkova J, Jancova E et al. Prevalence of permanent neonatal diabetes in Slovakia and successful replacement of insulin with sulfonylurea therapy in KCNJ11 and ABCC8 mutation carriers. J Clin Endocrinol Metab 2007 92 : 1276 1282.
18. Wiedemann B, Schober E, Waldhoer T, Koehle J, Flanagan SE, Mackay DJ et al. Incidence of neonatal diabetes in Austria - calculation based on the Austrian Diabetes Register. Pediatr Diabetes 2010 11 : 18 23.
19. Suzuki S, Makita Y, Mukai T, Matsuo K, Ueda O, Fujieda K. Molecular basis of neonatal diabetes in Japanese patients. J Clin Endocrinol Metab 2007 92 : 3979 3985.
20. Edghill EL, Dix RJ, Flanagan SE, Bingley PJ, Hattersley AT, Ellard S et al. HLA genotyping supports a non-autoimmune etiology in patients diagnosed with diabetes under the age of 6 months. Diabetes 2006 55 : 1895 1898.
21. Rosenbauer J, Icks A, Giani G. Incidence and prevalence of childhood type 1 diabetes mellitus in Germany - model-based national estimates. J Pediatr Endocrinol Metab 2002 15 : 1497 1504. (Pubitemid 36024234)
22. Stoy J, Greeley SA, Paz VP, Ye H, Pastore AN, Skowron KB et al. Diagnosis and treatment of neonatal diabetes: a United States experience. Pediatr Diabetes 2008 9 : 450 459.